drugset / Trial / NCT05065567
Haloperidol, Droperidol, Ondansetron in Cannabis Hyperemesis
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to compare two commonly used agents for the treatment of cyclic vomiting to see if one agent is inferior to the other in time to improvement in symptoms, need for repeat or rescue medications, treatment failures and complications/side effects.
Timeline
- Start
- 2021-08-30
- Primary completion
- 2023-11-20
- Completion
- 2023-11-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Droperidol | Small molecule | 2.5 mg | Intravenous |
| Comparator | Haloperidol | Other / unclassified | 5 mg | Intramuscular |
| Comparator | Ondansetron | Other / unclassified | 8 mg | Intravenous |